JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Inicio・Lista de Acciones・Pfizer

Search

Pfizer

Cerrado

SectorSanidad

26.41 0.46

Resumen

Variación precio

24h

Actual

Mínimo

26.01

Máximo

26.66

Métricas clave
By Trading Economics
Ingresos	-5.2B -1.6B
Ventas	903M 18B
P/B Media del Sector	19.699 67.147
BPA	0.66
Rentabilidad por dividendo	6.37
Margen de beneficios	-9.387
Empleados	75,000
EBITDA	-4.9B 756M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+9.81% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	6.37% 2.36%
Próximas Ganancias	5 may 2026
Fecha Próximo Dividendo	12 jun 2026
Próxima Fecha de Ex Dividendo	8 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	810M 152B
Apertura anterior	25.95
Cierre anterior	26.41

Noticias sobre sentimiento de mercado

By Acuity

30%

70%

100 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

22.855 / 23.85 Soporte y Resistencia

Pfizer Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 feb 2026, 12:25 UTC

Ganancias

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

23 abr 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

1 abr 2026, 20:07 UTC

Adquisiciones, fusiones, absorciones

Why 2026 Is Biotech's Comeback Year -- Barrons.com

11 mar 2026, 11:02 UTC

Charlas de Mercado

Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk

10 mar 2026, 12:50 UTC

Ganancias

BioNTech Stock Plunges 17% After Earnings. Why the Drugmaker Faces a Perfect Storm. -- Barrons.com

10 mar 2026, 11:18 UTC

Ganancias

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. -- Barrons.com

9 mar 2026, 09:43 UTC

Acciones populares

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

10 feb 2026, 21:51 UTC

Ganancias

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb 2026, 21:17 UTC

Ganancias

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 feb 2026, 21:36 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 19:56 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 19:46 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 feb 2026, 17:35 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 17:30 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

3 feb 2026, 13:50 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 13:06 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 12:45 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, PayPal, Teradyne, Tesla, Pfizer, AMD, Merck, and More -- Barrons.com

3 feb 2026, 12:02 UTC

Ganancias

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 feb 2026, 11:48 UTC

Ganancias

Pfizer: About 20 Key Pivotal Study Starts Planned for 2026 >PFE

3 feb 2026, 11:48 UTC

Ganancias

Pfizer: Enters 2026 With Clear Strategic Priorities, Growing Late-Stage Pipeline >PFE

3 feb 2026, 11:47 UTC

Ganancias

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

3 feb 2026, 11:46 UTC

Ganancias

Pfizer Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer Reaffirms 2026 Guidance >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer 4Q Rev $17.56B >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer 4Q Adj EPS 66c >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer 4Q Loss/Shr 29c >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer 4Q Loss $1.65B >PFE

3 feb 2026, 11:45 UTC

Ganancias

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

3 feb 2026, 10:41 UTC

Ganancias

These Stocks Are Today's Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, DaVita, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

Pfizer previsión

Precio Objetivo

By TipRanks

9.81% repunte

Estimación a 12 Meses

Media 28.88 USD 9.81%

Máximo 36 USD

Mínimo 25 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

20 ratings

6

Comprar

12

Mantener

2

Vender

De acuerdo con 20 analistas que ofrecen calificaciones bursátiles a para Pfizer Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bearish.

Sentimiento

By Acuity

100 / 347 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Otras acciones del sector

JNJ

Johnson and Johnson

225.57

UNH

UnitedHealth Group Inc

363.82

TMO

Thermo Fisher Scientific Inc

466.62

ISRG

Intuitive Surgical Inc

451.55

ABT

Abbott Laboratories

87.15

Live chat